Sacubitril / Valsartan
Sponsors
John Paul II Hospital, Krakow, Puerta de Hierro University Hospital, National Heart Institute, Egypt, University Clinical Hospital Mostar, Khawaja Danish Ali
Conditions
Acute Decompensated Heart Failure (ADHF)Chronic Kidney Disease (CKD)Decompensated Heart FailureHeart FailureHeart Failure Due to Coronary Artery DiseaseHeart Failure With Preserved Ejection Fraction (HFPEF)Heart Failure with Moderately Reduced Ejection FractionHemodialysis
Phase 1
Phase 2
Phase 3
The Effect of Sacubitril/valsartan Versus Ramipril on Left Ventricular Function and Remodeling in Patients with Ischemic Heart Failure with Mid-range Ejection Fraction
RecruitingNCT05508035
Start: 2023-07-13End: 2027-06-30Target: 666Updated: 2024-10-31
Effect of Angiotensin Receptor/Neprilysin Inhibitors on Transthyretin Cardiac Amyloidosis and Heart Failure with Reduced Ejection Fraction
Not yet recruitingNCT06712030
Start: 2025-01-31End: 2027-06-30Target: 114Updated: 2024-12-02
Phase 4
The Effect of Sacubitril and Valsartan on Heart Function in Chronic Hemodialysis Patients With HFpEF
CompletedNCT07417215
Start: 2026-01-30End: 2026-05-10Updated: 2026-05-20
Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology (DELAY-HF), Pilot Study
Not yet recruitingNCT07572032
Start: 2026-05-20End: 2028-12-20Target: 80Updated: 2026-05-07